Novo Nordisk

(NYSE) NVO

Current Price$46.06

Market Cap$154.70B

Since IPO (1981)+41,300%

5 Year+35%

1 Year-26%

1 Month+22%

Novo Nordisk Financials at a Glance

Market Cap

$154.70B

Revenue (TTM)

$327.80B

Net Income (TTM)

$121.96B

EPS (TTM)

$4.26

P/E Ratio

10.80

Dividend

$1.80

Beta (Volatility)

0.70 (Low)

Dividend

$1.80

Beta (Volatility)

0.70 (Low)

Price

$46.06

Volume

448,458

Open

$45.97

Price

$46.06

Volume

448,458

Open

$45.97

Previous Close

$46.06

Daily Range

$45.20 - $46.14

52-Week Range

$35.12 - $81.44

Dividend

$1.80

Beta (Volatility)

0.70 (Low)

Price

$46.06

Volume

448,458

Open

$45.97

Previous Close

$46.06

Daily Range

$45.20 - $46.14

52-Week Range

$35.12 - $81.44

NVO News

3 Absurdly Cheap Growth Stocks to Buy in May 2026

David Jagielski, CPAMay 4, 2026

Here's Why Shares in Agios Pharmaceuticals Soared This Week (And What to Expect Next in 2026)

Lee SamahaMay 2, 2026

Page 1

NVO: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Novo Nordisk

Industry

Pharmaceuticals

Sector

Health Care

Employees

68,794

CEO

Maziar Mike Doustdar

Website

www.novonordisk.com

Headquarters

Bagsvaerd, 2880, DK

NVO Financials

Key Financial Metrics (TTM)

Gross Margin

82%

Operating Margin

45%

Net Income Margin

37%

Return on Equity

74%

Return on Capital

44%

Return on Assets

22%

Earnings Yield

9.26%

Dividend Yield

3.91%

Payout Ratio

42.47%

Stock Overview

Market Cap

$154.70B

Shares Outstanding

3.36B

Volume

448.46K

Avg. Volume

20.30M

Financials (TTM)

Gross Profit

$250.28B

Operating Income

$127.66B

EBITDA

$156.73B

Operating Cash Flow

$119.10B

Capital Expenditure

$90.11B

Free Cash Flow

$28.99B

Cash & ST Invst.

$26.96B

Total Debt

$130.96B

Novo Nordisk Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$96.82B

+24.0%

Gross Profit

$83.22B

+27.7%

Gross Margin

85.96%

N/A

Market Cap

$154.70B

N/A

Market Cap/Employee

$2.00M

N/A

Employees

77,406

N/A

Net Income

$48.56B

+67.2%

EBITDA

$69.21B

+50.3%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Net Cash

$124.76B

-61.7%

Accounts Receivable

$100.27B

+16.1%

Inventory

$51.35B

+19.8%

Long Term Debt

$119.17B

+23.7%

Short Term Debt

$27.21B

+21.4%

Return on Assets

21.81%

N/A

Return on Invested Capital

44.45%

N/A

Free Cash Flow

$12.04B

+20.4%

Operating Cash Flow

$24.08B

-2.1%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

ABTAbbott Laboratories

ABTAbbott Laboratories$84.30-3.11%

GILDGilead Sciences, Inc.

GILDGilead Sciences, Inc.$131.33-2.04%

PFEPfizer Inc.

PFEPfizer Inc.$25.67-3.06%

TMOThermo Fisher Scientific Inc.

TMOThermo Fisher Scientific Inc.$465.00-2.01%

AMGNAmgen Inc.

AMGNAmgen Inc.$331.70+0.79%

SNYSanofi

SNYSanofi$43.31+0.30%

GSKGSK plc

GSKGSK plc$50.41-0.18%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

RXTRackspace Technology

RXTRackspace Technology$5.49+0.56%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$15.62+0.08%

POETPoet Technologies

POETPoet Technologies$10.95+0.14%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$76.28+0.07%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$42.57-0.07%

EOSEEos Energy Enterprises

EOSEEos Energy Enterprises$8.01+0.26%

OPENOpendoor Technologies

OPENOpendoor Technologies$5.01-0.06%

Questions About NVO

What is the current price of Novo Nordisk?

Novo Nordisk is trading at $46.06 per share.

What is the 52-week range for Novo Nordisk?

Over the past 52 weeks, Novo Nordisk has traded between $35.12 and $81.44.

How much debt does Novo Nordisk have?

As of the most recent reporting period, Novo Nordisk reported total debt of $22.57B.

How much cash does Novo Nordisk have on hand?

Novo Nordisk reported $3.26B in cash and cash equivalents in its most recent financial results.

What is Novo Nordisk’s dividend yield?

Novo Nordisk currently has a dividend yield of 3.91%.

Novo Nordisk

Novo Nordisk Financials at a Glance

NVO News

3 Absurdly Cheap Growth Stocks to Buy in May 2026

Here's Why Shares in Agios Pharmaceuticals Soared This Week (And What to Expect Next in 2026)

Is This Deal a Game Changer for Novo Nordisk?

Is Novo Nordisk's 72% Crash a Generational Buying Opportunity or a Value Trap?

Why Novo Nordisk's Pricing Shift Could Unlock a Much Larger Obesity Market

Could This New Approval Be a Turning Point For Novo Nordisk?

Novo Nordisk: A Strong Contender in the Pharmaceutical Arena

Can You Invest in Ozempic in 2026? Everything You Need to Know

NVO: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Novo Nordisk

NVO Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Novo Nordisk Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About NVO

What is the current price of Novo Nordisk?

What is the 52-week range for Novo Nordisk?

How much debt does Novo Nordisk have?

How much cash does Novo Nordisk have on hand?

What is Novo Nordisk’s dividend yield?

Premium Investing Services